[Translation] A randomized, controlled, double-blind, multicenter phase III clinical study of Envolimab combined with platinum-based doublet chemotherapy versus placebo combined with platinum-based doublet chemotherapy for neoadjuvant/adjuvant treatment of patients with resectable stage III non-small cell lung cancer.
比较恩沃利单抗联合化疗与安慰剂联合化疗新辅助/辅助治疗可手术切除非小细胞肺癌受试者的主要病理学缓解率和无事件生存期。
[Translation] Comparison of primary pathologic response rate and event-free survival in subjects with surgically resectable non-small cell lung cancer treated with envolizumab plus chemotherapy versus placebo plus chemotherapy in the neoadjuvant/adjuvant setting.